Lensar Inc (LNSR) financials

NASDAQ · Health Care

$5.84 -2.18% Close Oct 30, 2026 Live

Lensar revenue and earnings by year

Lensar's revenue was $58.4 million in the fiscal year to December 31, 2025, up 9.2% from the year before. Net income was -$34.3 million, -58.7% of revenue. Since the fiscal year to December 31, 2018, revenue has grown 13.3% a year on average.

RevenueNet income
$0$50.0M
20182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 8 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue5853423534263124
Revenue growth9.2%26.9%19.2%2.6%30.6%-13.6%25.2%—
Gross profit2726212018141311
Gross margin46.4%48.3%50.1%56.4%51.8%53.4%43.3%44.1%
Operating income-25-11-12-20-20-19-13-9
Operating margin-42.1%-19.9%-29.0%-57.1%-57.0%-70.1%-41.6%-38.2%
Net income-34-31-14-20-20-20-15-13
Net margin-58.7%-58.7%-34.1%-56.3%-56.9%-75.0%-48.0%-51.6%
Diluted EPS-$2.87-$2.73-$1.31-$1.96-$2.08———
Free cash flow-15-2-10-15-9-14-13-3

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open LNSR in Markets.

See also: LNSR returns

No forecast, no recommendation. This page describes Lensar Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.